Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-016-2 | CAS number: 9004-98-2 1 - 2.5 moles ethoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 37 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance with modified AF for differences in duration of exposure
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 850 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Basis for the calculation of the corrected inhalatory No-Observed-Adverse-Effect-Concentration (NOAEC) is a No-Observed-Adverse-Effect-Level (NOAEL) of 1000 mg/kg bw/day as determined in an oral combined repeated dose toxicity study with the reproduction / developmental toxicity screening test in the rat. Corrections for differences in respiratory volumes of laboratory animals and workers (1/0.38 = 2.63), for the respiratory volume in light activity (6.7/10 = 0.67), for the frequency of exposure (7/5 = 1.4) as well as for inhalative and oral bioavailability (0.75) were accounted for.
Corrected inhalatory NOAEC = NOAELoral, rat x (1/sRVrat) x (sRVhuman/wRV) x (ABSoral, rat/ABSinhal., human) x (fexpo, rat/fexpo, worker)
sRV: Standard respiratory volume
wRV: Respiratory volume of workers (8 h)
ABS: Absorption rate (oral absorption is assumed to be 75% of inhalation absorption as default)
fexpo: Frequency of exposure (rat: 7 days/week; workers: 5 days/week)
Corrected inhalatory NOAEC = 1000 x 2.63 x 0.67 x 0.75 x 1.4 = 1850 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator), starting point is NOAEL or NOAEC
- AF for differences in duration of exposure:
- 4
- Justification:
- ECHA default assessment factor (AF) for extrapolation subchronic (90-day) to chronic: 2; ECHA default AF for extrapolation subacute (28-day) to chronic: 6
Dosing duration in OECD 422 study used as basis for DNEL calculation: Males: 29 - 35 days; Females that delivered: 50 - 64 days; Females that failed to deliver: 41 -42 days.
Since most of the test animals were dosed for > 50 days (females that delivered), scaling of the AF for differences in exposure duration is justified.
Scaled AF: (50/28) x 2 = 1.8 x 2 = 3.6. Therefore, an AF of 4 is considered conservative enough to reflect the acutal dosing situation in the OECD 422 study used as basis for the DNEL calculation. - AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default (DNEL calculator), not relevant for inhalatory exposure as already considered in species-specific respiratory volumes
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 5
- Justification:
- Default (DNEL calculator), workers
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator), high quality study used to calculate DNEL
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 350 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance with modified AF for differences in duration of exposure
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 70 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Basis for the calculation of the corrected dermal No-Observed-Adverse-Effect-Level (NOAEL) is a NOAEL of 1000 mg/kg bw/day as determined in an oral combined repeated dose toxicity study with the reproduction / developmental toxicity screening test in the rat. Corrections for dermal and oral bioavailability (50.0) and differences in the frequency of exposure (7/5 = 1.4) were accounted for.
Corrected dermal NOAEL = NOAELoral, rat x (ABSoral, rat/ABSdermal, human) x (fexpo, rat/fexpo, worker)
ABS: Absorption rate (absorption rate in humans established to be 2%; correction of oral (rat) and dermal (human) bioavailability: 1/0.02 = 50.0)
fexpo: Frequency of exposure (rat: 7 days/week; workers: 5 days/week)
Corrected dermal NOAEL = 1000 x 50.0 x 1.4 = 70000 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator), starting point is NOAEL or NOAEC
- AF for differences in duration of exposure:
- 4
- Justification:
- ECHA default assessment factor (AF) for extrapolation subchronic (90-day) to chronic: 2; ECHA default AF for extrapolation subacute (28-day) to chronic: 6
Dosing duration in OECD 422 study used as basis for DNEL calculation: Males: 29 - 35 days; Females that delivered: 50 - 64 days; Females that failed to deliver: 41 -42 days.
Since most of the test animals were dosed for > 50 days (females that delivered), scaling of the AF for differences in exposure duration is justified.
Scaled AF: (50/28) x 2 = 1.8 x 2 = 3.6. Therefore, an AF of 4 is considered conservative enough to reflect the acutal dosing situation in the OECD 422 study used as basis for the DNEL calculation. - AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default (DNEL calculator), rat
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 5
- Justification:
- Default (DNEL calculator), workers
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator), high quality study used to calculate DNEL
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6.53 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance with modified AF for differences in duration of exposure
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 653 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Basis for the calculation of the corrected inhalatory No-Observed-Adverse-Effect-Concentration (NOAEC) is a No-Observed-Adverse-Effect-Level (NOAEL) of 1000 mg/kg bw/day as determined in an oral combined repeated dose toxicity study with the reproduction / developmental toxicity screening test in the rat. Corrections for differences in respiratory volumes of laboratory animals and the general population (1/1.15 = 0.87) and for inhalative and oral bioavailability (0.75) were accounted for.
Corrected inhalatory NOAEC = NOAELoral, rat x (1/sRVrat) x (ABSoral, rat/ABSinhal., human)
sRV: Standard respiratory volume
ABS: Absorption rate (oral absorption is assumed to be 75% of inhalation absorption as default)
Corrected inhalatory NOAEC = 1000 x 0.87 x 0.75 = 653 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator), starting point is NOAEL or NOAEC
- AF for differences in duration of exposure:
- 4
- Justification:
- ECHA default assessment factor (AF) for extrapolation subchronic (90-day) to chronic: 2; ECHA default AF for extrapolation subacute (28-day) to chronic: 6
Dosing duration in OECD 422 study used as basis for DNEL calculation: Males: 29 - 35 days; Females that delivered: 50 - 64 days; Females that failed to deliver: 41 -42 days.
Since most of the test animals were dosed for > 50 days (females that delivered), scaling of the AF for differences in exposure duration is justified.
Scaled AF: (50/28) x 2 = 1.8 x 2 = 3.6. Therefore, an AF of 4 is considered conservative enough to reflect the acutal dosing situation in the OECD 422 study used as basis for the DNEL calculation. - AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default (DNEL calculator), not relevant for inhalatory exposure as already considered in species-specific respiratory volumes
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 10
- Justification:
- Default (DNEL calculator), general population
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator), high quality study used to calculate DNEL
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 125 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance with modified AF for differences in duration of exposure
- Overall assessment factor (AF):
- 400
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Basis for the calculation of the corrected dermal No-Observed-Adverse-Effect-Level (NOAEL) is a NOAEL of 1000 mg/kg bw/day as determined in an oral combined repeated dose toxicity study with the reproduction / developmental toxicity screening test in the rat. A correction for dermal and oral bioavailability (50.0) was accounted for.
Corrected dermal NOAEL = NOAELoral, rat x (ABSoral, rat/ABSdermal, human)
ABS: Absorption rate (absorption rate in humans established to be 2%; correction of oral (rat) and dermal (human) bioavailability: 1/0.02 = 50.0)
Corrected dermal NOAEL = 1000 x 50.0 = 50000 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator), starting point is NOAEL or NOAEC
- AF for differences in duration of exposure:
- 4
- Justification:
- ECHA default assessment factor (AF) for extrapolation subchronic (90-day) to chronic: 2; ECHA default AF for extrapolation subacute (28-day) to chronic: 6
Dosing duration in OECD 422 study used as basis for DNEL calculation: Males: 29 - 35 days; Females that delivered: 50 - 64 days; Females that failed to deliver: 41 -42 days.
Since most of the test animals were dosed for > 50 days (females that delivered), scaling of the AF for differences in exposure duration is justified.
Scaled AF: (50/28) x 2 = 1.8 x 2 = 3.6. Therefore, an AF of 4 is considered conservative enough to reflect the acutal dosing situation in the OECD 422 study used as basis for the DNEL calculation. - AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default (DNEL calculator), rat
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 10
- Justification:
- Default (DNEL calculator), general population
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator), high quality study used to calculate DNEL
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance with modified AF for differences in duration of exposure
- Overall assessment factor (AF):
- 400
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No route-to-route extrapolation is required as the oral long-term DNEL for systemic effects is based on a No-Observed-Adverse-Effect-Level (NOAEL) of 1000 mg/kg bw/day as determined in an oral combined repeated dose toxicity study with the reproduction / developmental toxicity screening test in the rat.
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator), starting point is NOAEL or NOAEC
- AF for differences in duration of exposure:
- 4
- Justification:
- ECHA default assessment factor (AF) for extrapolation subchronic (90-day) to chronic: 2; ECHA default AF for extrapolation subacute (28-day) to chronic: 6
Dosing duration in OECD 422 study used as basis for DNEL calculation: Males: 29 - 35 days; Females that delivered: 50 - 64 days; Females that failed to deliver: 41 -42 days.
Since most of the test animals were dosed for > 50 days (females that delivered), scaling of the AF for differences in exposure duration is justified.
Scaled AF: (50/28) x 2 = 1.8 x 2 = 3.6. Therefore, an AF of 4 is considered conservative enough to reflect the acutal dosing situation in the OECD 422 study used as basis for the DNEL calculation. - AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default (DNEL calculator), rat
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 10
- Justification:
- Default (DNEL calculator), general population
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator), high quality study used to calculate DNEL
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.